Sign In
Buy MNK
$0.116
+0 (+0%)
At Close: Jul 20, 2022
Analysts Estimate Mallinckrodt (MNK) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 28'th Apr 2020
Mallinckrodt (MNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Global and Chinese Market for Paracetamol 2020, with Company Profiles of Key Players Including Mallinckrodt, Farmson and SPI Pharma
10:28am, Tuesday, 28'th Apr 2020
Dublin, April 28, 2020 -- The "Paracetamol Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology,.
Analysts Estimate Mallinckrodt (MNK) to Report a Decline in Earnings: What to Look Out for
12:00am, Tuesday, 28'th Apr 2020Aurinia Appoints Joe Miller as Chief Financial Officer
10:06am, Monday, 27'th Apr 2020
– Dennis Bourgeault to retire after more than 20 years with the company –VICTORIA, British Columbia & ROCKVILLE, Md. — Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia…
Aurinia Appoints Joe Miller as Chief Financial Officer
10:05am, Monday, 27'th Apr 2020
Aurinia Appoints Joe Miller as Chief Financial Officer
Mallinckrodt PLC Forecasted to Post FY2020 Earnings of $5.37 Per Share (NYSE:MNK)
06:42am, Monday, 27'th Apr 2020
Mallinckrodt PLC (NYSE:MNK) – Research analysts at SVB Leerink lowered their FY2020 earnings per share estimates for shares of Mallinckrodt in a note issued to investors on Thursday, April 23rd. SVB
Bank of New York Mellon Corp Decreases Holdings in Mallinckrodt PLC (NYSE:MNK)
08:46am, Saturday, 25'th Apr 2020
Bank of New York Mellon Corp decreased its stake in Mallinckrodt PLC (NYSE:MNK) by 60.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange C
Mallinckrodt PLC (NYSE:MNK) Given Consensus Recommendation of "Hold" by Brokerages
07:18am, Saturday, 25'th Apr 2020
Shares of Mallinckrodt PLC (NYSE:MNK) have been assigned an average rating of “Hold” from the eighteen analysts that are presently covering the stock, Marketbeat reports. Four research analysts ha
PAVmed FDA Approval, And Other News: The Good, Bad And Ugly Of Biopharma
06:27pm, Friday, 24'th Apr 2020
PAVmed's carpal tunnel syndrome device CarpX is approved. Prothena's Parkinson's study flops, taking the stock down. Mallinckrodt's kidney failure drug applicat
Cerecor Announces Changes to Board of Directors
05:45pm, Friday, 24'th Apr 2020
Cerecor Inc. (CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, today announced that Dr. Sol J.
Pune, April 24, 2020 -- The global opioid use disorder market size is projected to reach USD 4.50 billion by 2026, exhibiting a CAGR of 10.8% during the forecast period..
Mallinckrodt initiated with a Sell at Citi MNK
10:58am, Friday, 24'th Apr 2020
Mallinckrodt initiated with a Sell at Citi Citi MNK
$697.45 Million in Sales Expected for Mallinckrodt PLC (NYSE:MNK) This Quarter
08:00am, Friday, 24'th Apr 2020
Equities analysts predict that Mallinckrodt PLC (NYSE:MNK) will report sales of $697.45 million for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made estimat
Mallinckrodt PLC (NYSE:MNK) Expected to Earn Q1 2020 Earnings of $1.32 Per Share
05:22am, Thursday, 23'rd Apr 2020
Mallinckrodt PLC (NYSE:MNK) – Piper Sandler cut their Q1 2020 EPS estimates for Mallinckrodt in a research note issued to investors on Monday, April 20th. Piper Sandler analyst D. Amsellem now expec
CMG, CLDX among premarket gainers
01:19pm, Wednesday, 22'nd Apr 2020
SAExploration Holdings (NASDAQ:SAEX) +177% on $27M new project in Greece.B.O.S. Better Online Solutions (NASDAQ:BOSC) +56% on $1M order.The Peck Company Holdings (NASDAQ:PECK) +51% on partnership w
